Defining the genomic landscape of head and neck cancers through next‐generation sequencing. (30th April 2014)

• Record Type: Journal Article
• Authors: Rizzo, G; Black, M; Mymryk, JS; Barrett, JW; Nichols, AC
• Is Part Of: Oral diseases. Volume 21:Number 1(2015:Jan.)
• Page Start: e11
• Page End: e24
• Publication Date: 2014-04-30
• Subjects: Mouth -- Diseases -- Research -- Periodicals; 617.522
• DOI: 10.1111/odi.12246
• Languages: English
• ISSNs: 1354-523X

Abstract

<abstract abstract-type="main" id="odi12246-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Next‐generation sequencing (NGS) has revolutionized the field of genomics and improved our understanding of cancer biology. Advances have been achieved by sequencing tumor DNA and using matched normal DNA to filter out germ line variants to identify cancer‐specific changes. The identification of high incidences of activating mutations in head and neck squamous cell carcinoma (HNSCC) amenable to drug targeting has been made, with clear distinctions between the mutational profile of HPV‐positive and HPV‐negative tumors. This wealth of new understanding undoubtedly ameliorates our understanding of HNSCC cancer biology and elucidates clear targets for drug targeting which will guide future personalized medicine.</p> </abstract>